Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Jan 2013
Randomized Controlled Trial Multicenter StudyOmega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
The aim of this study was to evaluate the efficacy of polyunsaturated fatty acids (n-3 PUFA) for the prevention of recurrent atrial fibrillation (AF) in patients with normal sinus rhythm. ⋯ Pharmacological supplementation with 1 g of n-3 PUFA for 1 year did not reduce recurrent AF. (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation [FORWARD]; NCT00597220).
-
J. Am. Coll. Cardiol. · Jan 2013
Randomized Controlled TrialPredicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
The aim of this study was to derive and validate a model to predict survival in candidates for HeartMate II (HMII) (Thoratec, Pleasanton, California) left ventricular assist device (LVAD) support. ⋯ The HMRS might be useful for mortality risk stratification in HMII candidates and may serve as an additional tool in the patient selection process.